Minimize Uncertainty – Make Informed Decisions – Succeed

Hematology

Hematology Today—December 8, 2025

December 8, 2025artificial intelligence,astrazeneca,Multiple Myeloma,Sickle Cell Disease,BioPharma and Tech News,CAR T Therapy,Marginal Zone Lymphoma,Pirtobrutinib,Hematology News,Myelodysplastic syndromeschronic lymphocytic leukemia,Breyanzi

This week in Hematology, we spotlight the most relevant updates, approvals, and…

by LucidQuest

Onco_background

Oncology Today—December 8, 2025

December 8, 2025Paradigm Health,GIMEMA Cooperative Group,takeda,Philadelphia chromosome positive acute lymphoblastic leukemia,Multiple Myeloma,Indolent non Hodgkin lymphoma,BioPharma and Tech News,Advanced melanoma,Lymphoma,Innovent Biologics,Oncology News,flatiron health,Natera,Astrin Biosciences,Fred Hutchinson Cancer Center,ALX Oncology,Rare cancersOsteosarcoma,Foresight Diagnostics

This week’s oncology roundup covers major advances in targeted therapy,…

by LucidQuest

Oncology News

Oncology Video Recap—December 8, 2025

December 8, 2025Astrin Biosciences,NCI,astrazeneca,SWOG,breast cancer,Fred Hutchinson Cancer Center,BioPharma and Tech News,ALX Oncology,gastric cancer,Urothelial carcinoma,follicular lymphoma,Rare cancers,Marginal Zone Lymphoma,Osteosarcoma,Small Cell Lung Cancer,Indolent B-cell non Hodgkin lymphoma,Acute Myeloid Leukemia,Oncology News,Avenzo Therapeutics,gastroesophageal junction cancer,PharmaMarSwissmedic,Kelun Biotech

Explore our biweekly Oncology video recap highlighting major regulatory wins,…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: SciNeuro Pharmaceuticals $53M financing

December 8, 2025clinical trials,market access,Neurodegeneration,biopharma,Lucid Diligence Brief,payer access,diligence,venture fundingCNS therapeutics

Lucid Diligence Brief: SciNeuro Pharmaceuticals $53M financing Professional…

by Timos Papagatsias

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: OTR Therapeutics Series A $100 million backed by Pfizer Ventures

December 7, 2025clinical trials,market access,Regulatory,biopharma,Lucid Diligence Brief,payer access,diligence,venture financing,R&D strategy,China biotechJPM 2026

Lucid Diligence Brief: OTR Therapeutics Series A $100 million backed by Pfizer…

by Timos Papagatsias

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Triana Biomedicines $120M Series B for TRI-611 in ALK+ NSCLC

December 6, 2025Oncology,clinical trials,NSCLC,biopharma,Lucid Diligence Brief,payer access,venture financing,targeted protein degradation,molecular glues,CNS metastasesALK inhibitors

Lucid Diligence Brief: Triana Biomedicines $120M Series B for TRI-611 in ALK+…

by Timos Papagatsias

SABCS 2025 Preview: Key Breast Cancer Highlights to Watch

December 5, 2025Our Insights,breast cancercarboplatin,precision oncology,Conference Previews,venetoclax,Metastatic Breast Cancer,Benign Breast Disease,Chemotherapy,Aromatase Inhibitors,Ovarian Function Suppression,Letrozole,Palbociclib,SABCS 2025

Get ready for SABCS25 with LucidQuest’s concise preview of the sessions…

by LucidQuest

Vaccines

Vaccines Today—December 5, 2025

December 5, 2025BioPharma and Tech News,DEMENTIAcancer vaccine,shingles vaccine,WHO,GC Biopharma,Vaccine news,varicella vaccine,pertussis,BPZE1,ILiAD Biotechnologies,Datar Cancer Genetics

This week’s vaccines update highlights key clinical findings, regulatory…

by LucidQuest

Respiratory

Respiratory Today—December 5, 2025

December 5, 2025biosimilars,gene therapy,astrazeneca,sanofi,RSV,COPD,Asthma,BioPharma and Tech News,pulmonary arterial hypertension,Respiratory Newscipla,Alpha-1 antitrypsin deficiency

This week’s respiratory update highlights major developments across RSV…

by LucidQuest

Public_Health

Public Health Today—5 December, 2025

December 5, 2025HIV,Depression,BioPharma and Tech News,obesity,METABOLIC HEALTH,Public Health News,adolescent mental health,broadly neutralizing antibodies,GLP-1 agonists,psychiatric geneticsbreast cancer genomics,nitrous oxide

This Public Health weekly update highlights new evidence shaping behavioural,…

by LucidQuest

ASH 2025_Preview_by_LucidQuest

ASH 2025 Preview: Key Hematology Highlights to Watch

December 5, 2025Our Insights,Multiple MyelomaSickle Cell Disease,Hodgkin Lymphoma,Acute Myeloid Leukemia,Large B-cell lymphoma,Conference Previews,B-cell acute lymphoblastic leukemia,American Society of Hematology,European Hematology Association,Diffuse large B-cell lymphoma,Chronic myeloid leukemia,Venous thromboembolism

ASH 2025 at a glance Get ready for ASH 2025 with LucidQuest’s concise preview.…

by LucidQuest

Public_Health

Public Health Video Recap—December 5, 2025

December 5, 2025Amgen,astrazeneca,Asthma,BioPharma and Tech News,rheumatoid arthritis,Tezepelumab,Artificial sweeteners,Public Health News,oral steroids,peptibody mRNA therapy,protein binder designadolescent smartphone exposure,pneumonia

This biweekly Public Health video recap brings together key advances across…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.